It’s Made Major Strides in the Market
When it was approved in 2002, Botox was only approved to treat cross-eyes, uncontrollable blinking, cervical dystonia (a neurological disorder that causes severe neck and shoulder contractions), and moderate to severe frown lines between the eyebrows. As we know, it now has a much longer list of approvals and studies (good-bye excessive sweating!), with more manufacturers introducing new neurotoxin options, like Dysport and Xeomin, to the market. 
